In full agreement with our molecular and cellular data, our survival results suggest that the poor prognosis conferred by the RIPMSI mutation is more significant in the context of MLH1 deficiency. This evidence concerns the gene MLH1 and hyperinsulinemic hypoglycemia, familial, 4.